XML 128 R60.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-based compensation expense and income tax benefits recognized during the periods
The following table provides information on share-based compensation expense and income tax benefits recognized in 2012, 2011 and 2010:
 
 
Years ended December 31,
 
 
2012
 
2011
 
2010
 
 
(In thousands)
Stock option and stock purchase plans
 
$
9,469

 
9,497

 
9,069

Nonvested stock
 
9,395

 
7,926

 
7,474

Share-based compensation expense
 
18,864

 
17,423

 
16,543

Income tax benefit
 
(6,309
)
 
(5,794
)
 
(5,572
)
Share-based compensation expense, net of tax
 
$
12,555

 
11,629

 
10,971

Summary of share-based compensation expense recognized related to cash awards
The following table is a summary of compensation expense recognized related to cash awards in addition to share-based compensation expense reported in the previous table.
 
 
Years ended December 31
 
 
2012
 
2011
 
2010
 
 
(In thousands)
Cash awards
 
$
1,099

 
1,882

 
2,052

Summary of stock option activity
The following is a summary of option activity under our stock option plans as of and for the year ended December 31, 2012:
 
 
Shares
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic  Value
 
 
(In thousands)
 
 
 
(In years)
 
(In thousands)
Options outstanding at January 1
 
3,297

 
$
44.25

 
 
 
 
Granted
 
456

 
53.63

 
 
 
 
Exercised
 
(508
)
 
38.68

 
 
 
 
Forfeited or expired
 
(97
)
 
48.92

 
 
 
 
Options outstanding at December 31
 
3,148

 
$
46.36

 
3.6
 
$
18,566

Vested and expected to vest at December 31
 
3,077

 
$
46.31

 
3.1
 
$
18,313

Exercisable at December 31
 
2,032

 
$
45.76

 
2.6
 
$
14,106

Information about options in various price ranges
Information about options in various price ranges at December 31, 2012 follows:
 
 
Options Outstanding
 
Options Exercisable
Price Ranges
 
Shares
 
Weighted-
Average
Remaining
Contractual
Term
 
Weighted-
Average  Exercise
Price
 
Shares
 
Weighted-
Average  Exercise
Price
 
 
(In thousands)
 
(In years)
 
 

 
(In thousands)
 
 
Less than $45.00
 
1,131
 
3.4
 
$
33.82

 
881
 
$
34.05

45.00-50.00
 
617
 
5.1
 
49.38

 
204
 
49.38

50.00-55.00
 
897
 
3.6
 
53.04

 
452
 
52.48

55.00 and over
 
503
 
2.2
 
58.96

 
495
 
58.96

Total
 
3,148
 
3.6
 
$
46.36

 
2,032
 
$
45.76

Summary of Nonvested stock awards
The following is a summary of the status of Ryder’s nonvested restricted stock awards as of and for the year ended December 31, 2012:
 
 
Time-Vested
 
Market-Based Vested
 
 
Shares
 
Weighted-
Average
Grant Date
Fair Value
 
Shares
 
Weighted-
Average
Grant Date
Fair Value
 
 
(In thousands)
 
 
 
(In thousands)
 
 
Nonvested stock outstanding at January 1
 
373
 
$
46.72

 
476
 
$
18.69

Granted
 
129
 
52.38

 
93
 
43.39

Vested
 
(47)
 
39.10

 
 

Forfeited
 
(15)
 
49.76

 
(182)
 
32.20

Nonvested stock outstanding at December 31
 
440
 
$
49.16

 
387
 
$
25.35

Summary of Employee Stock Purchase Plan
The following table summarizes the status of Ryder’s ESPP:
 
 
Shares
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic  Value
 
 
(In thousands)
 
 
 
(In years)
 
(In thousands)
Outstanding at January 1
 

 
$

 
 
 
 
Granted
 
268

 
33.72

 
 
 
 
Exercised
 
(268
)
 
33.72

 
 
 
 
Forfeited or expired
 

 

 
 
 
 
Outstanding at December 31
 

 
$

 

 
$

Exercisable at December 31
 

 
$

 

 
$

Weighted-average assumptions used for options granted
The following table presents the weighted-average assumptions used for options granted:
 
 
Years ended December 31,
  
 
2012
 
2011
 
2010
Option plans:
 
 
 
 
 
 
Expected dividends
 
2.2%
 
2.2%
 
3.0%
Expected volatility
 
40.7%
 
38.7%
 
43.9%
Risk-free rate
 
0.6%
 
1.7%
 
1.7%
Expected term in years
 
3.7 years
 
3.6 years
 
3.4 years
Grant-date fair value
 
$14.07
 
$12.88
 
$8.93
Purchase plan:
 
 
 
 
 
 
Expected dividends
 
2.7%
 
2.4%
 
2.5%
Expected volatility
 
32.7%
 
32.8%
 
35.6%
Risk-free rate
 
0.1%
 
0.1%
 
0.2%
Expected term in years
 
0.25 years
 
0.25 years
 
0.25 years
Grant-date fair value
 
$9.53
 
$10.21
 
$8.95